Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02858648 · ClinicalTrials.gov registry record · NA
Diabetes Go Mobile! Pilot Study
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02858648: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT02858648 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02858648, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether a behavioral lifestyle intervention using mobile smart phone technology for self-monitoring can lead to greater improvements in diabetes outcomes.
Interventions
- BEHAVIORAL Behavior intervention with smart phone based self-monitoring
- BEHAVIORAL Behavior intervention with paper diary based self-monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT02858648 record still lists
NCT02858648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavior intervention with smart phone based self-monitoring is the first listed.
NCT02858648 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02858648 about?
NCT02858648 is a clinical study titled "Diabetes Go Mobile! Pilot Study". The purpose of this study is to examine whether a behavioral lifestyle intervention using mobile smart phone technology for self-monitoring can lead to greater improvements in diabetes outcomes.
What is the current status of trial NCT02858648?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2013-01. Estimated completion is 2013-08.
What interventions are being tested in trial NCT02858648?
The interventions under investigation include: Behavior intervention with smart phone based self-monitoring (BEHAVIORAL), Behavior intervention with paper diary based self-monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT02858648?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02858648's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia